Pediatric heart transplantation from donors with depressed ventricular function: An analysis of the united network of organ sharing database

Circulation: Heart Failure

Volumn 6, Issue 6, 2013, Pages 1223-1229

  Rossano, Joseph W ^a   Lin, Kimberly Y ^a   Paridon, Stephen M ^a   Zhang, Xuemei ^a   Gaynor, J William ^b   Kaufman, Beth D ^a   Shaddy, Robert E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Pediatrics; Survival; Transplantation

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DATA BASE; DEPRESSED VENTRICULAR FUNCTION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DONOR; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; COMPARATIVE STUDY; EPIDEMIOLOGY; FOLLOW UP; HEART STROKE VOLUME; INFANT; MORTALITY; NEWBORN; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; SURGERY; TRENDS; UNITED STATES; METHODOLOGY; PEDIATRICS; STATISTICS; SURVIVAL; TRANSPLANTATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PATIENT SELECTION; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TISSUE DONORS; UNITED STATES; VENTRICULAR DYSFUNCTION; WAITING LISTS;

PEDIATRICS; SURVIVAL; TRANSPLANTATION;

EID: 84892662450     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000029     Document Type: Article

References (32)

1. Rossano JW, Kim JJ, Decker JA, Price JF, Zafar F, Graves DE, Morales DL, Heinle JS, Bozkurt B, Towbin JA, Denfield SW, Dreyer WJ, Jefferies JL. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012;18:459-470.
2. Organ procurement and transplantation network website. Available at http://optn.Transplant.Hrsa.Gov/latestdata/rptdata.Asp. Accessed March 26, 2012.
3. Mah D, Singh TP, Thiagarajan RR, Gauvreau K, Piercey GE, Blume ED, Fynn-Thompson F, Almond CS. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009;28:1292-1298.
4. Almond CS, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ, Fynn-Thompson F, Singh TP. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119:717-727.
5. Bailey LL, Razzouk AJ, Hasaniya NW, Chinnock RE. Pediatric transplantation using hearts refused on the basis of donor quality. Ann Thorac Surg. 2009;87:1902-1908; discussion 1908.
6. Paul JJ, Tani LY, Shaddy RE, Minich LL. Spectrum of left ventricular dysfunction in potential pediatric heart transplant donors. J Heart Lung Transplant. 2003;22:548-552.
7. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D?Alessandro A, Dec GW, Edwards NM, Higgins RS, Jeevanandum V, Kauffman M, Kirklin JK, Large SR, Marelli D, Peterson TS, Ring WS, Robbins RC, Russell SD, Taylor DO, Van Bakel A, Wallwork J, Young JB. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002;106:836-841.
8. Jeevanandam V, Furukawa S, Prendergast TW, Todd BA, Eisen HJ, McClurken JB. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996;62:1268-1275.
9. Jeevanandam V, Todd B, Regillo T, Hellman S, Eldridge C, McClurken J. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant. 1994;13:681-687; discussion 685.
10. Lyons JM, Pearl JM, McLean KM, Akhter SA, Wagner CJ, Pandalai PK, Duffy JY. Glucocorticoid administration reduces cardiac dysfunction after brain death in pigs. J Heart Lung Transplant. 2005;24:2249-2254.
11. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant. 1995;14:734-742.
12. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 1995;59:58-62.
13. Boucek MM, Mathis CM, Kanakriyeh MS, McCormack J, Razzouk A, Gundry SR, Bailey L. Donor shortage: use of the dysfunctional donor heart. J Heart Lung Transplant. 1993;12(6 Pt 2):S186-S190.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: A report from the American Society of Echocardiography?s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
15. Detsky AS. Regional variation in medical care. N Engl J Med. 1995;333:589-590.
16. Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med. 1995;333:565-572.
17. O?Hare AM, Rodriguez RA, Hailpern SM, Larson EB, Kurella Tamura M. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. Jama. 2010;304:180-186.
18. Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga TB, Borgers M, Plets C, Flameng W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87:230-239.
19. Cohen O, De La Zerda DJ, Beygui R, Hekmat D, Laks H. Donor brain death mechanisms and outcomes after heart transplantation. Transplant Proc. 2007;39:2964-2969.
20. Karamlou T, Shen I, Slater M, Crispell K, Chan B, Ravichandran P. Decreased recipient survival following orthotopic heart transplantation with use of hearts from donors with projectile brain injury. J Heart Lung Transplant. 2005;24:29-33.
21. Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 2004;43:806-810.
22. Singhal AK, Sheng X, Drakos SG, Stehlik J. Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc. 2009;41:3539-3544.
23. Ganesh JS, Rogers CA, Banner NR, Bonser RS. Donor cause of death and medium-term survival after heart transplantation: a United Kingdom national study. J Thorac Cardiovasc Surg. 2005;129:1153-1159.
24. Zhuo Y, Li SH, Chen MS, Wu J, Kinkaid HY, Fazel S, Weisel RD, Li RK. Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. J Thorac Cardiovasc Surg. 2010;139:1286-1294, 1294.e1.
25. Lesnefsky EJ, Gallo DS, Ye J, Whittingham TS, Lust WD. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. J Lab Clin Med. 1994;124:843-851.
26. Liu M, Zhang P, Chen M, Zhang W, Yu L, Yang XC, Fan Q. Aging might increase myocardial ischemia/reperfusion-induced apoptosis in humans and rats. Age (Dordr). 2012;34:621-632.
27. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res. 2009;83:247-261.
28. Schulman D, Latchman DS, Yellon DM. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2001;281:H1630-H1636.
29. Rhodes SS, Camara AK, Heisner JS, Riess ML, Aldakkak M, Stowe DF. Reduced mitochondrial Ca2+ loading and improved functional recovery after ischemia-reperfusion injury in old vs. young guinea pig hearts. Am J Physiol Heart Circ Physiol. 2012;302:H855-H863.
30. Gupta D, Piacentino V 3rd, Macha M, Singhal AK, Gaughan JP, McClurken JB, Goldman BI, Fisher CA, Beltramo D, Monacchio J, Eisen HJ, Furukawa S. Effect of older donor age on risk for mortality after heart transplantation. Ann Thorac Surg. 2004;78:890-899.
31. Nagji AS, Hranjec T, Swenson BR, Kern JA, Bergin JD, Jones DR, Kron IL, Lau CL, Ailawadi G. Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation. Ann Thorac Surg. 2010;90:168-175.
32. Pedotti P, Mattucci DA, Gabbrielli F, Venettoni S, Costa AN, Taioli E. Analysis of the complex effect of donor?s age on survival of subjects who underwent heart transplantation. Transplantation. 2005;80:1026-1032.